nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ABCB1—Topotecan—cervical cancer	0.22	1	CbGbCtD
Doxazosin—Lung neoplasm malignant—Topotecan—cervical cancer	0.0715	0.16	CcSEcCtD
Doxazosin—Paresis—Topotecan—cervical cancer	0.0393	0.0882	CcSEcCtD
Doxazosin—KCNH6—renal system—cervical cancer	0.0282	0.0842	CbGeAlD
Doxazosin—KCNH6—uterus—cervical cancer	0.0251	0.075	CbGeAlD
Doxazosin—KCNH6—female reproductive system—cervical cancer	0.0226	0.0674	CbGeAlD
Doxazosin—Rash erythematous—Topotecan—cervical cancer	0.0187	0.042	CcSEcCtD
Doxazosin—Rigors—Topotecan—cervical cancer	0.0176	0.0394	CcSEcCtD
Doxazosin—ADRA1D—epithelium—cervical cancer	0.0168	0.0503	CbGeAlD
Doxazosin—ADRA1B—renal system—cervical cancer	0.0159	0.0477	CbGeAlD
Doxazosin—Rash maculo-papular—Topotecan—cervical cancer	0.013	0.0292	CcSEcCtD
Doxazosin—ADRA1D—female reproductive system—cervical cancer	0.0125	0.0374	CbGeAlD
Doxazosin—Sepsis—Topotecan—cervical cancer	0.0125	0.0279	CcSEcCtD
Doxazosin—ORM1—endometrium—cervical cancer	0.0124	0.0371	CbGeAlD
Doxazosin—Ear pain—Topotecan—cervical cancer	0.0122	0.0274	CcSEcCtD
Doxazosin—ORM1—female reproductive system—cervical cancer	0.0103	0.0308	CbGeAlD
Doxazosin—ADRA1A—epithelium—cervical cancer	0.00966	0.0289	CbGeAlD
Doxazosin—Cramp muscle—Topotecan—cervical cancer	0.00938	0.021	CcSEcCtD
Doxazosin—KCNH2—uterine cervix—cervical cancer	0.00925	0.0277	CbGeAlD
Doxazosin—ADRA1A—renal system—cervical cancer	0.00896	0.0268	CbGeAlD
Doxazosin—KCNH2—renal system—cervical cancer	0.00865	0.0259	CbGeAlD
Doxazosin—Neutropenia—Topotecan—cervical cancer	0.00842	0.0189	CcSEcCtD
Doxazosin—KCNH2—endometrium—cervical cancer	0.00837	0.025	CbGeAlD
Doxazosin—Weight increased—Topotecan—cervical cancer	0.00819	0.0184	CcSEcCtD
Doxazosin—Pneumonia—Topotecan—cervical cancer	0.00807	0.0181	CcSEcCtD
Doxazosin—KCNH2—uterus—cervical cancer	0.00771	0.0231	CbGeAlD
Doxazosin—Sweating—Topotecan—cervical cancer	0.00769	0.0173	CcSEcCtD
Doxazosin—Epistaxis—Topotecan—cervical cancer	0.00757	0.017	CcSEcCtD
Doxazosin—ADRA2A—uterine cervix—cervical cancer	0.00728	0.0218	CbGeAlD
Doxazosin—Rhinitis—Topotecan—cervical cancer	0.00722	0.0162	CcSEcCtD
Doxazosin—Hypoaesthesia—Topotecan—cervical cancer	0.00717	0.0161	CcSEcCtD
Doxazosin—Pharyngitis—Topotecan—cervical cancer	0.00715	0.016	CcSEcCtD
Doxazosin—ADRA2A—decidua—cervical cancer	0.00694	0.0207	CbGeAlD
Doxazosin—KCNH2—female reproductive system—cervical cancer	0.00693	0.0207	CbGeAlD
Doxazosin—ADRA2A—endometrium—cervical cancer	0.00659	0.0197	CbGeAlD
Doxazosin—CYP2C19—vagina—cervical cancer	0.00657	0.0196	CbGeAlD
Doxazosin—Chills—Topotecan—cervical cancer	0.00646	0.0145	CcSEcCtD
Doxazosin—ADRA2A—mammalian vulva—cervical cancer	0.00637	0.0191	CbGeAlD
Doxazosin—Alopecia—Topotecan—cervical cancer	0.00637	0.0143	CcSEcCtD
Doxazosin—KCNH2—female gonad—cervical cancer	0.00631	0.0189	CbGeAlD
Doxazosin—Malnutrition—Topotecan—cervical cancer	0.00627	0.0141	CcSEcCtD
Doxazosin—KCNH2—vagina—cervical cancer	0.00627	0.0187	CbGeAlD
Doxazosin—ADRA2A—uterus—cervical cancer	0.00607	0.0181	CbGeAlD
Doxazosin—Back pain—Topotecan—cervical cancer	0.00607	0.0136	CcSEcCtD
Doxazosin—Muscle spasms—Topotecan—cervical cancer	0.00603	0.0135	CcSEcCtD
Doxazosin—ORM1—lymph node—cervical cancer	0.00602	0.018	CbGeAlD
Doxazosin—Ill-defined disorder—Topotecan—cervical cancer	0.00582	0.013	CcSEcCtD
Doxazosin—Malaise—Topotecan—cervical cancer	0.00566	0.0127	CcSEcCtD
Doxazosin—Leukopenia—Topotecan—cervical cancer	0.00561	0.0126	CcSEcCtD
Doxazosin—Cough—Topotecan—cervical cancer	0.00547	0.0123	CcSEcCtD
Doxazosin—ADRA2A—female reproductive system—cervical cancer	0.00546	0.0163	CbGeAlD
Doxazosin—Chest pain—Topotecan—cervical cancer	0.00534	0.012	CcSEcCtD
Doxazosin—Myalgia—Topotecan—cervical cancer	0.00534	0.012	CcSEcCtD
Doxazosin—Arthralgia—Topotecan—cervical cancer	0.00534	0.012	CcSEcCtD
Doxazosin—CYP2D6—renal system—cervical cancer	0.00528	0.0158	CbGeAlD
Doxazosin—Discomfort—Topotecan—cervical cancer	0.00528	0.0118	CcSEcCtD
Doxazosin—Infection—Topotecan—cervical cancer	0.00509	0.0114	CcSEcCtD
Doxazosin—Thrombocytopenia—Topotecan—cervical cancer	0.00501	0.0112	CcSEcCtD
Doxazosin—Skin disorder—Topotecan—cervical cancer	0.00497	0.0111	CcSEcCtD
Doxazosin—ADRA2A—female gonad—cervical cancer	0.00497	0.0148	CbGeAlD
Doxazosin—Hyperhidrosis—Topotecan—cervical cancer	0.00495	0.0111	CcSEcCtD
Doxazosin—ADRA2A—vagina—cervical cancer	0.00494	0.0148	CbGeAlD
Doxazosin—Anorexia—Topotecan—cervical cancer	0.00488	0.0109	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00466	0.0105	CcSEcCtD
Doxazosin—Paraesthesia—Topotecan—cervical cancer	0.0046	0.0103	CcSEcCtD
Doxazosin—Dyspnoea—Topotecan—cervical cancer	0.00456	0.0102	CcSEcCtD
Doxazosin—Dyspepsia—Topotecan—cervical cancer	0.00451	0.0101	CcSEcCtD
Doxazosin—Decreased appetite—Topotecan—cervical cancer	0.00445	0.00998	CcSEcCtD
Doxazosin—Fatigue—Topotecan—cervical cancer	0.00441	0.00989	CcSEcCtD
Doxazosin—Constipation—Topotecan—cervical cancer	0.00438	0.00981	CcSEcCtD
Doxazosin—Pain—Topotecan—cervical cancer	0.00438	0.00981	CcSEcCtD
Doxazosin—CYP2D6—female reproductive system—cervical cancer	0.00423	0.0126	CbGeAlD
Doxazosin—Feeling abnormal—Topotecan—cervical cancer	0.00422	0.00946	CcSEcCtD
Doxazosin—Gastrointestinal pain—Topotecan—cervical cancer	0.00419	0.00938	CcSEcCtD
Doxazosin—ABCB1—epithelium—cervical cancer	0.00409	0.0122	CbGeAlD
Doxazosin—Urticaria—Topotecan—cervical cancer	0.00407	0.00912	CcSEcCtD
Doxazosin—ABCB1—uterine cervix—cervical cancer	0.00406	0.0121	CbGeAlD
Doxazosin—KCNH2—lymph node—cervical cancer	0.00405	0.0121	CbGeAlD
Doxazosin—Abdominal pain—Topotecan—cervical cancer	0.00405	0.00907	CcSEcCtD
Doxazosin—Body temperature increased—Topotecan—cervical cancer	0.00405	0.00907	CcSEcCtD
Doxazosin—ABCB1—decidua—cervical cancer	0.00387	0.0116	CbGeAlD
Doxazosin—CYP2D6—female gonad—cervical cancer	0.00385	0.0115	CbGeAlD
Doxazosin—ABCB1—renal system—cervical cancer	0.0038	0.0114	CbGeAlD
Doxazosin—Hypersensitivity—Topotecan—cervical cancer	0.00377	0.00846	CcSEcCtD
Doxazosin—Asthenia—Topotecan—cervical cancer	0.00367	0.00823	CcSEcCtD
Doxazosin—ABCB1—endometrium—cervical cancer	0.00367	0.011	CbGeAlD
Doxazosin—Pruritus—Topotecan—cervical cancer	0.00362	0.00812	CcSEcCtD
Doxazosin—ABCB1—mammalian vulva—cervical cancer	0.00355	0.0106	CbGeAlD
Doxazosin—Diarrhoea—Topotecan—cervical cancer	0.0035	0.00785	CcSEcCtD
Doxazosin—Dizziness—Topotecan—cervical cancer	0.00339	0.00759	CcSEcCtD
Doxazosin—ABCB1—uterus—cervical cancer	0.00338	0.0101	CbGeAlD
Doxazosin—Vomiting—Topotecan—cervical cancer	0.00325	0.0073	CcSEcCtD
Doxazosin—Rash—Topotecan—cervical cancer	0.00323	0.00724	CcSEcCtD
Doxazosin—Dermatitis—Topotecan—cervical cancer	0.00322	0.00723	CcSEcCtD
Doxazosin—Headache—Topotecan—cervical cancer	0.00321	0.00719	CcSEcCtD
Doxazosin—ADRA2A—lymph node—cervical cancer	0.00319	0.00954	CbGeAlD
Doxazosin—Nausea—Topotecan—cervical cancer	0.00304	0.00682	CcSEcCtD
Doxazosin—ABCB1—female reproductive system—cervical cancer	0.00304	0.00909	CbGeAlD
Doxazosin—ABCB1—female gonad—cervical cancer	0.00277	0.00827	CbGeAlD
Doxazosin—ABCB1—vagina—cervical cancer	0.00275	0.00822	CbGeAlD
Doxazosin—ABCB1—lymph node—cervical cancer	0.00178	0.00532	CbGeAlD
